Home Ingredients Zinc Acetate
Immune SupportRespiratory Health

Zinc Acetate

Evidence Level
Strong
2 Clinical Trials
5 Documented Benefits
4/5 Evidence Score

Zinc acetate is zinc bound to acetic acid, a well-absorbed form that is among the best studied in cold lozenges, where it may release zinc ions effectively in the mouth and throat to help shorten a cold when started at the first sign of symptoms. As a daily supplement it supports immune function, skin, wound healing, and many enzymes. Cold-lozenge use involves specific higher short-term amounts for just a few days, while general supplementation provides 15 to 30 mg of elemental zinc. Long-term daily intake above about 40 mg should be avoided, since chronic high zinc can deplete copper; taking it with a little food limits nausea.

Studied Dose 13–23 mg elemental zinc per lozenge for cold use (75–100 mg/day total); 50 mg three times daily for Wilson's disease (prescription)
Active Compound Zinc acetate

Benefits

Common Cold Treatment (Cold-Eeze)

Zinc acetate lozenges (Cold-Eeze) reduce cold duration when started within 24 hours of symptoms. Some Hemilä meta-analyses suggest zinc acetate may have slight edge over gluconate (more zinc ion release at saliva pH).

Supported by Trial 1

Wilson's Disease Treatment (pharmaceutical)

Zinc acetate (Galzin®) is FDA-approved for Wilson's disease — a genetic disorder of copper metabolism causing copper accumulation in liver, brain, and other organs. High-dose zinc acetate (50 mg elemental zinc TID) induces metallothionein in intestinal cells, sequestering dietary copper and preventing absorption. Prescription only; requires hepatology supervision.

Supported by Trial 2

Bioavailability

Zinc acetate is well-absorbed — among the well-bioavailable forms. Releases zinc ions readily at saliva and gastric pH.

Supported by Trial 1, Trial 2

Standard Zinc Benefits

Same general zinc benefits as other forms — immune support, skin/wound healing, growth/development, taste/smell, antioxidant function.

Supported by Trial 1, Trial 2

Reasonable Cost

Zinc acetate is cost-comparable to gluconate; a reasonable choice for both supplementation and lozenge applications.

Supported by Trial 1, Trial 2

Mechanism of action

1

Zinc Ion Release at Throat pH

Hemilä's research suggests zinc acetate releases more zinc ions in saliva than zinc gluconate — basis for slight cold-treatment advantage. The clinically relevant variable is total Zn²⁺ concentration in throat mucosa during lozenge dissolution.

2

Wilson's Disease Mechanism (Metallothionein Induction)

High-dose oral zinc acetate induces metallothionein in enterocytes — a small protein that binds and sequesters copper. Dietary copper binds metallothionein, fails to absorb, and is shed with intestinal epithelial cells into stool. Effective copper elimination strategy.

3

Acetic Acid Release

Acetic acid (vinegar) is well-tolerated and rapidly metabolized to acetyl-CoA — innocuous at supplemental amounts.

4

Standard Zinc Enzyme Functions

Same as other zinc forms — >300 enzyme cofactor, zinc finger transcription factors, antioxidant via Cu/Zn-SOD.

Clinical trials

1
Zinc Acetate vs Gluconate for Common Cold — Hemilä

Subgroup analyses within Hemilä Cochrane pooled analyses comparing zinc acetate vs zinc gluconate lozenges for cold duration.

Pooled across cold lozenge clinical trials.

Both forms reduce cold duration vs placebo; zinc acetate may have modest edge over gluconate (~40% vs ~28% duration reduction). Both effective when started within 24 hours.

2
Zinc Acetate for Wilson's Disease

Trials of zinc acetate (50 mg elemental zinc TID) in Wilson's disease patients for maintenance therapy after initial chelation.

Wilson's disease patients.

Zinc acetate effectively maintains negative copper balance in Wilson's disease — induces intestinal metallothionein blocking copper absorption. FDA-approved (Galzin®) for Wilson's. Prescription pharmaceutical use.

Side effects and drug interactions

Common Potential side effects

GI distress (nausea, gastritis) — common particularly at high-dose Wilson's dosing.
Bad/metallic taste with lozenges.
Mouth dryness with lozenges.
Copper deficiency at chronic high doses — may be intentional in Wilson's disease but adverse in general supplementation.
ANOSMIA — same FDA warning re intranasal forms; do not use intranasal zinc.

Important Drug interactions

Tetracycline/quinolone antibiotics — chelation; separate by 2 hours.
Bisphosphonates — separate by 2 hours.
Penicillamine (used in Wilson's) — both reduce copper but combined could over-deplete; specialist supervision.
Iron, calcium — competition at high doses.
Trientine (alternative Wilson's drug) — interaction; specialist coordination.

More Immune Support Ingredients

Immune Support
Vitamin C
Vitamin C (L-ascorbic acid) is a water-soluble essential nutrient that humans cannot synth…
Immune Support
Zinc
Zinc, an essential trace mineral, is commonly supplemented in forms like zinc gluconate, a…
Immune Support
Vitamin A
Vitamin A is a fat-soluble nutrient essential for vision, immune defense, reproduction, an…
Immune Support
EpiCor® (Postbiotic Yeast Fermentate — Cargill)
EpiCor® is a postbiotic ingredient from Cargill — derived from the fermentation of Sacchar…

Explore Other Ingredients

Antioxidant
Setria® Glutathione
Setria® is Kyowa Hakko's patented reduced L-glutathione (GSH) produced via fermentation —…
Cognitive
Citicoline
Citicoline (CDP-choline) is a naturally-occurring intermediate in phosphatidylcholine bios…
Antioxidant
Milk Thistle
Milk thistle, derived from the Silybum marianum plant, contains silymarin, a compound know…

Frequently asked questions about Zinc Acetate

What is zinc acetate?

Zinc acetate is zinc bound to acetic acid. It is well absorbed and is one of the forms studied in cold lozenges, where it may be particularly effective at releasing zinc ions in the mouth and throat.

Is zinc acetate good for colds?

Zinc acetate lozenges are among the best-studied for shortening colds, with some research suggesting they may work slightly better than gluconate at this. They are used as a short course of lozenges started at the first sign of symptoms.

How much zinc acetate should I take?

Cold-lozenge studies use specific higher short-term amounts for a few days only. For general daily supplementation, 15 to 30 mg of elemental zinc is typical. Avoid long-term daily intake above about 40 mg without medical advice.

When should I take zinc acetate?

For colds, dissolve lozenges in the mouth as directed at the onset of symptoms. For daily use, take it with a little food if needed and away from calcium, iron, and coffee.

What is Zinc Acetate used for?

Zinc Acetate is researched primarily for Immune Support and Respiratory Health. Zinc acetate lozenges (Cold-Eeze) reduce cold duration when started within 24 hours of symptoms. Some Hemilä meta-analyses suggest zinc acetate may have slight edge over gluconate (more zinc ion release at saliva pH).

What is the recommended dosage of Zinc Acetate?

The clinically studied dose is 13–23 mg elemental zinc per lozenge for cold use (75–100 mg/day total); 50 mg three times daily for Wilson's disease (prescription) Always follow the product label and check with a healthcare provider for personal advice.

Is Zinc Acetate safe, and does it have side effects?

For most healthy adults, Zinc Acetate is well tolerated at studied doses. Reported effects can include: GI distress (nausea, gastritis) — common particularly at high-dose Wilson's dosing. Bad/metallic taste with lozenges. It may also interact with some medications. Zinc Acetate is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Zinc Acetate interact with any medications?

Possible interactions include: Tetracycline/quinolone antibiotics — chelation; separate by 2 hours. Bisphosphonates — separate by 2 hours. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Zinc Acetate?

NutraSmarts rates the evidence for Zinc Acetate as Strong (4 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Hemila H Zinc lozenges may shorten the duration of colds: a systematic review. The Open Respiratory Medicine Journal. 2011;5:51-58. doi: 10.2174/1874306401105010051.PubMedUsed to support: Supports the cold-duration claim: this systematic review found zinc lozenges (notably zinc acetate releasing ionic zinc) can shorten colds. Honest framing: the effect is formulation- and dose-dependent and the overall cold evidence remains mixed.
  2. Prasad AS, Beck FW, Bao B, Snell D, Fitzgerald JT Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. The Journal of Infectious Diseases. 2008;197(6):795-802. doi: 10.1086/528803.PubMedUsed to support: A randomized placebo-controlled trial of zinc acetate lozenges showing shorter, less severe colds with anti-inflammatory marker changes. Honest framing: a single small RCT; benefit depends on adequate ionic-zinc delivery and is not consistently reproduced.
  3. Brewer GJ Zinc acetate for the treatment of Wilson's disease. Expert Opinion on Pharmacotherapy. 2001;2(9):1473-1477. doi: 10.1517/14656566.2.9.1473.PubMedUsed to support: Supports zinc acetate as standard maintenance therapy for Wilson's disease via blockade of intestinal copper absorption. Honest framing: the very copper-blocking mechanism means chronic high-dose zinc can cause copper deficiency.
  4. Nault D, Machingo TA, Shipper AG, Antiporta DA, Hamel C, Nourouzpour S, et al. Zinc for prevention and treatment of the common cold. The Cochrane Database of Systematic Reviews. 2024;5(5):CD014914. doi: 10.1002/14651858.CD014914.pub2.PubMedUsed to support: An authoritative Cochrane review of zinc (including acetate lozenges) for colds. Honest framing: it concluded the evidence is of low/very-low certainty and benefits are inconsistent, underscoring that cold efficacy is still unproven and formulation-dependent.